Copyright
©The Author(s) 2019.
World J Crit Care Med. Feb 21, 2019; 8(2): 9-17
Published online Feb 21, 2019. doi: 10.5492/wjccm.v8.i2.9
Published online Feb 21, 2019. doi: 10.5492/wjccm.v8.i2.9
Survivor | Non survivor | P valuea | |
Age (yr)1 | 61.6 ± 17.0 | 68.5 ± 15.6 | 0.01 |
Male | 34.2 % (27) | 65.8% (52) | 0.9 |
Female | 35.1% (26) | 64.9% (48) | |
Baseline laboratory values | |||
Potassium (mmol/L)1 | 4.3 ± 1.1 | 4.6 ± 1.1 | 0.05 |
Serum lactate (mmol/L)1 | 5.0 ± 3.7 | 8.6 ± 7.0 | 0.001 |
Glucose (mg/dL)1 | 171 ± 86 | 184 ± 114 | 0.5 |
Platelet (thousand/cu mm)1 | 217 ± 122 | 201 ± 121 | 0.47 |
pH1 | 7.3 ± 0.15 | 7.2 ± 0.2 | 0.03 |
Initial cardiac rhythm | |||
Pulseless electrical activity | 33.7% (34) | 66.3% (67) | 0.49 |
Ventricular fibrillation | 54.5% (6) | 45.5% (5) | |
Pulseless ventricular tachycardia | 50% (3) | 50% (3) | |
Asystole | 34.8% (8) | 65.2% (15) |
- Citation: Patel VH, Vendittelli P, Garg R, Szpunar S, LaLonde T, Lee J, Rosman H, Mehta RH, Othman H. Neutrophil-lymphocyte ratio: A prognostic tool in patients with in-hospital cardiac arrest. World J Crit Care Med 2019; 8(2): 9-17
- URL: https://www.wjgnet.com/2220-3141/full/v8/i2/9.htm
- DOI: https://dx.doi.org/10.5492/wjccm.v8.i2.9